Developing a cardiovascular disease risk factor annotated corpus of
  Chinese electronic medical records by Su, Jia et al.
1 
 
Developing a cardiovascular disease risk factor annotated corpus of Chinese electronic 
medical records 
Jia Su1, Bin He2, Yi Guan3,*, Jingchi Jiang4, Jinfeng Yang5 
Address: 1, 2, 3, 4 Language Technology Research Center, School of Computer Science and 
Technology, Harbin Institute of Technology, Harbin, China; 5 School of Software, Harbin 
University of Science and Technology, Harbin, China 
Email: 1 sujiahit@gmail.com; 2 hebin_hit@foxmail.com; 3 guanyi@hit.edu.cn; 4 
jiangjingchi0118@163.com; 5 fondofbeyond@163.com  
* Corresponding author: Yi Guan, Room 803, Zonghe Building, Harbin Institute of Technology, 
No. 92 West Dazhi Street, Harbin, Heilongjiang, China; guanyi@hit.edu.cn; +86-18686748550 
 
ABSTRACT 
Background: Cardiovascular disease (CVD) has become the leading cause of death in China, 
and most of the cases can be prevented by controlling risk factors. The goal of this study was 
to build a corpus of CVD risk factor annotations based on Chinese electronic medical records 
(CEMRs). This corpus is intended to be used to develop a risk factor information extraction 
system that, in turn, can be applied as a foundation for the further study of the progress of risk 
factors and CVD. 
Results: We designed a light annotation task to capture CVD risk factors with indicators, 
temporal attributes and assertions that were explicitly or implicitly displayed in the records. 
The task included: 1) preparing data; 2) creating guidelines for capturing annotations (these 
were created with the help of clinicians); 3) proposing an annotation method including building 
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the guidelines draft, training the annotators and updating the guidelines, and corpus 
construction. Meanwhile, we proposed some creative annotation guidelines: (1) the under-
threshold medical examination values were annotated for our purpose of studying the progress 
of risk factors and CVD; (2) possible and negative risk factors were concerned for the same 
reason, and we created assertions for annotations; (3) we added four temporal attributes to CVD 
risk factors in CEMRs for constructing long term variations. Then, a risk factor annotated 
corpus based on de-identified discharge summaries and progress notes from 600 patients was 
developed. Built with the help of clinicians, this corpus has an inter-annotator agreement (IAA) 
F1-measure of 0.968, indicating a high reliability.  
Conclusion: To the best of our knowledge, this is the first annotated corpus concerning CVD 
risk factors in CEMRs and the guidelines for capturing CVD risk factor annotations from 
CEMRs were proposed. The obtained document-level annotations can be applied in future 
studies to monitor risk factors and CVD over the long term. 
KEYWORDS  
Cardiovascular disease risk factors, Chinese electronic medical records, annotation, corpus 
construction, information extraction 
 
BACKGROUND 
Introduction 
Cardiovascular disease (CVD) has become the first death cause throughout the world; 
there were approximately 17.5 million deaths from CVD in 2012, most of which occurred in 
low- and middle-income countries [1]. In China, CVD occupies the leading position among 
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causes of death and is responsible for 2 out of every 5 deaths [2]. This situation deeply affects 
the health of the Chinese people and is a heavy burden on society. Fortunately, most CVD can 
be prevented by controlling the malleable risk factors such as specific medical conditions and 
the adoption of unhealthy life-styles at early stages [3]. A risk factor is a pattern of behavior or 
physical characteristic of a group of individuals that increases the probability of the future 
occurrence of one or more diseases in that group relative to comparable groups without or with 
different levels of the behavior or characteristic [4]. Risk factors, including specific medical 
conditions such as hypertension and hyperglycemia/diabetes, unhealthy life-style choices such 
as smoking and alcohol abuse, and other factors such as age and family history, can have 
prominent effects on the progress of CVD [3, 5]. Therefore, monitoring these risk factors 
constitutes an important approach in avoiding CVD. 
A Chinese electronic medical record (CEMR) is a storage medium suitable for 
extracting CVD risk factors and monitoring. Actually, an electronic medical record (EMR) 
stores all health care data and information in electronic formats, along with the associated 
information processing and knowledge support tools necessary for the managing the health 
enterprise system [6]. The availability of large amounts of individual health narratives in 
CEMRs make this resource suitable for study by natural language processing (NLP) techniques 
especially information extraction (IE) techniques [7]. In 2010, the ministry of health in China 
published the basic norms of medical records writing [8] and the basic norms of electronic 
medical records [9], making these data more normative. Together, these characteristics make 
CEMR an effective medium for studies that involve extracting CVD risk factors. Some related 
works [7, 10—21] have been performed, but no studies have been conducted on CVD risk 
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factors based on CEMRs. To do this, we designed a task to extract CVD risk factors from 
CEMRs. 
To perform the extraction, we developed a CVD risk factor annotated corpus based on 
CEMRs because in the biomedical field the utilized corpora are far less than other open fields 
and a specific corpus is critically important in building an IE system. The purpose of this corpus 
is to act as the basis for developing an automatic risk factor extraction system. Subsequently, a 
monitoring platform could be established based on this extraction system that can help 
supervise CVD risk factors over time. Furthermore, based on the risk factors (along with other 
health information) that are comprehensively stored over long durations, a method that could 
predict the trend of each risk factor, help manage chronic diseases (such as hypertension and 
diabetes) and estimate the progress of CVD could also be included in the platform. To build 
the corpus, we proposed a light annotation task [22]. As the first step, we annotated 600 patients’ 
de-identified discharge summaries and progress notes from CEMRs. 
Our work is similar to the 2014 i2b2/UTHealth risk factor annotation shared task [23]. 
We adopted some technologies from that task, but also made some creations: (1) we proposed 
12 CVD risk factors to be annotated including alcohol abuse, chronic kidney disease which 
were not considered in that task based on the advices of medical experts after considering the 
characteristics of CEMRs; (2) positive, possible, negative information and under-threshold 
examination values form a part of one’s health condition and can be used to develop a long 
term supervision system, so these information were appended for our annotations; (3) for a 
long term monitoring, time information is critical, so we created temporal attributes for 
marking the occurrence time of risk factors in CEMRs. 
5 
 
Related work 
Related works based on English EMRs 
The 2006 Informatics for Integrating Biology and the Bedside (i2b2) shared task 
focused on identifying patients’ smoking statuses from medical discharge records. In this task, 
928 records covering five categories were annotated by two pulmonologists [24]. The 2008 
i2b2 Obesity Challenge was an organized competition intend to find ways to recognize obesity 
and comorbidities from discharge summaries and classify them into four classes: Present, 
Absent, Questionable, and Unmentioned. An annotated data set was provided [25]. In 2009, 
the challenge focused on extracting medication information from medical records, including 
the names of medications, their dosages, modes and frequencies of administration, treatment 
durations, and reasons for administration [26, 27]. The challenge included a set of annotated 
discharge summaries. In 2010, the challenge involved a concepts, assertions, and relations 
identification task in which participants were given an annotated gold-standard corpus for 
system training [28]. The Sixth i2b2 Natural Language Processing Challenge concerned the 
issues involved in recognizing temporal relations in clinical records; it provided a corpus of 
annotated discharge summaries with temporal information [29, 30]. Subsequently, the 2014 
i2b2/UTHealth NLP project focused on identifying risk factors for Cardiac Artery Disease in 
the narrative texts of EMRs, providing a set of 1,304 annotated medical records [31, 32]. In 
2016, the challenge was to classify psychotic patients into four severities based on their 
neuropsychiatric clinical records; 433 annotated records were provided for training [33]. 
Projects such as the ShARe/CLEF eHealth Evaluation Lab 2013, were devoted to 
solving the difficulties involved in understanding the professional expressions (such as non-
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standard abbreviations, and ward-specific idioms) that clinicians use when describing their 
patients [34, 35]. This project provided annotated corpora for system building. Another 
important project was undertaken during SemEval 2015. Its clinical TempEval sub-task was 
similar to the i2b2 2012 NLP shared task in that participants were asked to find ways to 
recognize temporal information, clinical events, and their relations in clinical narratives. This 
project used a manually annotated corpus based on 600 clinical notes and pathology reports 
[36]. Another SemEval 2015 subtask involved analyzing clinical text, which involves named 
entity recognition and template field completion. This subtask used the ShARe corpus of 
annotated clinical text [35, 37]. Meystre et al. [38] proposed a new IE system for a congestive 
heart failure performance measure based on clinical notes from 1,083 Veterans Health 
Administration patients. Domain experts’ annotated notes were created to act as a gold standard. 
Ford et al. [39] reported that information extracted from text in EMRs does improve case 
detection when combined with proper coding. 
Related works based on CEMRs 
Wang et al. [16] focused on recognizing and normalizing the names of symptoms in 
traditional Chinese medicine EMRs. To perform judgements, this system used a set of manually 
annotated clinical symptom names. Jiang et al. [14] proposed a complete annotation scheme 
for building a corpus of word segmentation and part-of-speech (POS) from CEMRs. Yang et 
al. [11] focused on designing an annotation scheme and constructing a corpus of named entities 
and entity relationships from CEMRs; they formulated an annotation specification and built a 
corpus based on 992 medical discharge summaries and progress notes. Lei [17] and Lei et al. 
[18] focused on recognizing named entities in Chinese medical discharge summaries. They 
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classified the entities into four categories: clinical problems, procedures, labs, and medications. 
Finally, they annotated an entities corpus based on CEMRs. Xu et al. [19] studied a joint model 
that performed segmentation and named entity recognition in Chinese discharge summaries 
and built a set of 336 annotated Chinese discharge summaries. Wang et al. [20] researched the 
extraction of tumor-related information from Chinese-language operation notes of patients with 
hepatic carcinomas, and annotated a corpus contains 961 entities. He et al. [21] proposed a 
comprehensive corpus of syntactic and semantic annotations from Chinese clinical texts. 
Despite the similar intent of these works, research into extracting CVD risk factors from 
CEMRs has not yet been studied. Meanwhile, for the IE tasks in the biomedical field, the 
number of accessible corpora is far fewer than those for more general extractions. However, 
corpora are important for building IE system. Thus, constructing a CVD risk factor annotated 
corpus is both a necessary and fundamental task. Moreover, unlike annotation tasks for texts 
that require less specialized knowledge, linguists require the assistance of medical experts to 
perform annotations in the biomedical field.  
MATERIALS AND METHODS 
A light annotation task 
Compared with traditional NLP tasks such as segmentation, POS tagging, parsing, and 
semantic analysis, annotating CVD risk factors from CEMRs is a task that is both distinctive 
and light. As Stubbs says [22], we need only create a light annotation task for risk factor 
annotation rather than implementing all the NLP tasks. Therefore, based on the annotation trials 
conducted by Stubbs and Uzuner [32], we built a light annotation task that focuses solely on 
annotations of CVD risk factors with indicators, temporal attributes, and assertions and that 
8 
 
does not require other NLP tasks. Meanwhile, an exhaustive annotation strategy— (we 
annotated all the occurrences of a CVD risk factor in CEMR narratives no matter how many 
times they appeared) —was applied. Notably, during the annotation trials, the increased time 
consumption caused by the exhaustive annotation strategy was subsequently offset by a higher 
level of inter-annotator agreement (IAA) and reduced difficulty for the annotators. 
Data 
We obtained a snapshot of medical records from the Second Affiliated Hospital of 
Harbin Medical University (a large general hospital that offers clinical services, medical 
education, scientific research, disease prevention, healthcare and rehabilitation) for all of 2012. 
The data included images of the medical records for approximately 140,000 patients from 35 
departments and 87 sub-departments, ranging from pediatrics to the (Intensive Care Unit) ICU. 
To function as annotation tasks for CVD risk factors, we selected a subset of CEMRs from 600 
patients composed of 344 randomly selected cardiovascular patients, 190 cardiovascular 
surgery patients, and 66 other departments. Each patient’s medical records contained a series 
of documents consisting of their discharge summary, progress notes, medical examination 
reports, electrocardiograms etc. The discharge summaries and progress notes were regarded as 
the most important free text in these records [7]. A discharge summary is used to summarize 
the entire therapeutic process and treatment outcome, while progress notes record the clinical 
manifestations, medical examinations and treatment periodicity. Therefore, we regarded 
discharge summaries and progress notes for the 600 patients described above as suitable for 
annotation. 
Next, the records were preprocessed as follows: (1) we used an optical character 
9 
 
recognition (OCR) tool, “Tesseract,” [40] to convert the original record images into text; (2) 
we manually fixed errors after the OCR process was complete and removed identifying 
information such as patient names, addresses, hospital IDs and doctor names; (3) we encoded 
the text into Extensible Markup Language (XML) format and added a title section using an 
XML node. Figure 1 shows an example of a progress note in XML format after preprocessing 
and ready for annotation. 
 
Figure 1. A sample progress note after preprocessing 
 
Annotation guidelines 
A light annotation task involves annotating the CVD risk factors with indicators, 
temporal attributes and assertions from the narratives in the CEMRs. Based on the CEMR 
characteristics and clinician suggestions, the guidelines for annotating this information are 
10 
 
presented as follows. 
CVD risk factors and indicators 
An indicator is used to indicate the existence of a risk factor that may not be explicitly 
recorded in the narratives of CEMRs but exist in a cryptic form (e.g., “最高血压达 150/100 
mmHg” (the highest blood pressure (Bp) is 150/100 mmHg) indicates a hypertensive patient). 
Explicitly mentioned risk factors and indirect expressions such as tests or treatments that can 
indicate the existence of risk factors are given equal status. Even indirect information (e.g., 
quantitative values from medical examinations) can be meaningful because it captures 
additional details about a patient’s condition. With the assistance of medical experts, we 
proposed to annotate a set of CVD risk factors that include Overweight/Obesity (O2), 
Hypertension, Diabetes, Dyslipidemia, Chronic Kidney Disease (CKD), Atherosis, Obstructive 
Sleep Apnea Syndrome (OSAS), Smoking, Alcohol Abuse (A2), Family History of CVD 
(FHCVD), Age and Gender, and exploited the indicators of these risk factors. Table 1 lists all 
12 types of risk factors, and this is the first time concerning those risk factors in CEMRs. The 
risk factors are in the left column and the indicators are on the right. 
 
Table 1 CVD risk factors and their indicators 
Risk factors Indicators 
O2  Mention: A diagnosis of patient overweight or obesity, e.g., 
“肥胖” (obesity) 
Hypertension  Mention: A diagnosis or history of hypertension, e.g., “高血
压病史 20 年” (a history of hypertension for 20 years) 
 High Bp: A measurement of Bp or a description of the 
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patient’s high Bp, e.g., Bp 150/100 mmHg  
 Regulate Bp: A description of Bp regulation or unsuccessful 
regulation, e.g., “控制血压” (regulating Bp) 
 Blood pressure drug: Patient takes medicine which is 
confirmed to control Bp, e.g., “口服降压药” (patient is taking 
hypotensor) 
Diabetes  Mention: A diagnosis or a history of diabetes, e.g., “糖尿病” 
(diabetes) 
 High blood glucose: A measurement of blood glucose or a 
description of the patient’s high blood glucose, e.g., blood 
glucose: “随机血糖：14.5 mmol/L” (Random Blood Glucose 
(RBG): 14.5 mmol/L) 
 Regulate blood glucose: A description of blood glucose 
regulation or unsuccessful regulation, e.g., “ 调 节 血 糖 ” 
(regulating the glucose) 
 Hypoglycemic drug: Patient takes medications confirmed to 
control blood glucose, e.g., “规律用胰岛素” (patient takes 
insulin regularly) 
Dyslipidemia  Mention: A diagnosis of dyslipidemia, hyperlipidemia or a 
history of hyperlipidemia, e.g., “高血脂史 ” (a history of 
hyperlipidemia) 
 High blood lipids: A measurement of blood lipids or a 
description of the patient’s high blood lipids, e.g., TG 
(triglyceride): 1.96 mmol/L 
 Regulate blood lipids: A description of blood lipids regulation 
or unsuccessful regulation, e.g., “降脂” (to lower serum lipids) 
 Lipid-lowering drug: Patient takes medicine that is 
confirmed to control blood lipids, e.g., “治疗计划：立普妥 20 
mg Qn po” (Treatment plan: Lipitor (atorvastatin calcium) 20 
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mg, take orally, once per night) 
CKD  Mention: A diagnosis of CKD, e.g., “慢性肾炎” (chronic 
nephritis) 
Atherosis  Mention: A diagnosis of atherosclerosis or atherosclerotic 
plaque, e.g., “冠脉粥样斑块” (atherosclerotic plaque) 
OSAS  Mention: A diagnosis of OSAS, e.g., “阻塞型睡眠呼吸暂停
综合症” (OSAS) 
Smoking  Mention: Smoking or a patient history of smoking, e.g., “吸
烟 40 余年” (smoking over 40 years) 
 Smoking cessation: A description of smoking cessation or 
that the patient has not yet quit smoking, e.g., “未戒烟” (the 
patient has not yet quit smoking) 
 Smoking amount: A description of how much the patient 
smokes, e.g., “每天 20 支” (20 cigarettes per day) 
A2  Mention: Alcohol abuse, e.g., “长期大量饮酒史” (a long 
history of heavy drinking) 
 Drinking amount: A description of how much the patient 
drinks, e.g., “2 两/日”（数值要大于 1）(100 grams of white 
spirit consumption per day (the number should be over 50 g)) 
FHCVD  Mention: Patient has a family history of CVD or has a first-
degree relative (parents, siblings, or children) who has a 
history of CVD, e.g., “哥哥有冠心病病史” (the patient’s 
brother has a history of CVD) 
Age  Mention: The age of the patient, e.g., “66 岁” (66 years old) 
 Age group: The age group of the patient, e.g., “老
年”(elderly) 
Gender  Mention: The gender of patient, e.g., “女性” (female) 
 
Notably, with the goal of being able to construct a timeline of CVD risk factors, we 
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annotated all the quantitative values from medical examinations regardless of whether they 
exceeded the threshold (e.g., a patient whose Bp is 120/80 mmHg is also annotated for 
hypertension, even though the measurement is below the 140/90 mmHg criterion [5]). This was 
done so that all the test values would be extracted and we could later build a clear picture of 
changes in risk factors over time. 
Temporal attributes 
To construct a health condition timeline, collecting temporal annotations is essential. 
Considering the time at which the indicators occurred and the characteristics of CEMRs, we 
proposed to divide the risk factors into four time-dependent categories: before the duration of 
hospital stay (DHS) (the risk factor occurred before the DHS), during the DHS, after the DHS, 
and continuing (the risk factor is continuous). For instance, “平时血压 130/90 mmHg” (a 
patient whose ordinary Bp is 130/90 mmHg) is regarded as the “High Bp” indicator of 
hypertension with time before the DHS; “查体：Bp 130/80 mmHg” (physical examination: Bp 
130/80 mmHg) indicates that the “High Bp” of Hypertension was made during the DHS; “出
院医嘱：调节血糖” (doctor advice to a patient after discharge: to regulate blood glucose) 
indicates that the diabetes indicator of “Regulate Blood Glucose” occurred after the DHS; and 
“身材肥胖” (obesity) which is usually unchangeable over the short term would be annotated 
as a “Mention” of O2 with time continuing. In this way, changes in risk factors can be clearly 
presented. For example, “no indicators of diabetes were presented during the previous DHS, 
but evidence shows that the patient exhibited diabetic indicators before the next DHS; therefore, 
the diabetes occurred between the two DHSs.” Notably, age and gender were not included in 
the temporal annotations. 
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Assertions 
In contrast to the works of Stubbs and Uzuner [32], we are the first to propose assertions 
of risk factors. For example, “无糖尿病病史” (patient does not have a history of diabetes) 
needs to be considered, because such text show that the patient did not previously have diabetes. 
Based on whether the assertion of the risk factor actually occurred on the patient, we created 
two modifiers: associated or not associated with the patient. Further, risk factors associated 
with the patient are divided into three categories: present, absent and possible. Overall, 
assertions can be summarized as follows: 
 Present: the risk factor definitely occurred on the patient, e.g., “平时血压
130/90 mmHg” (the patient’s ordinary Bp is 130/90 mmHg) 
 Absent: the risk factor was considered for the patient, but was negative, e.g., 
“无糖尿病病史” (the patient does not have a history of diabetes) 
 Possible: the risk factor may possibly have occurred on the patient, e.g., “临床
初步诊断：糖尿病” (Primary diagnosis: diabetes) 
 Not associated with the patient: the risk factor occurred on others, e.g., “弟患
糖尿病” (the patient’s brother has diabetes) 
Annotation method 
The annotation method involves three major tasks: drafting the guidelines, training the 
annotators and updating the guidelines, and corpus construction. These tasks can be seen in 
Figure 2. 
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Figure 2. The flowchart for CVD risk factor annotation method 
 
Drafting the guidelines 
Based on the annotation guidelines discussed above, the linguists created a preliminary 
draft of the annotation guidelines that included all 12 CVD risk factors, indicators, temporal 
attributes, and assertions along with their definitions, as well as some positive annotations 
(expressions which should be marked) and negative annotations (expressions which should not 
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be marked). Some sample annotation attempts were conducted under this draft using an 
annotation tool developed specifically for this task. Figure 3 shows a sample annotation.  
 
Figure 3. A sample annotation for CVD risk factors 
 
Using the sample annotations, errors and inappropriate rules in the preliminary draft 
were corrected, and additional positive and negative examples were added to the draft. This 
process continued until no further modifications were needed; at that point, the specifications 
were considered to be suitable for the next workflow step. 
Training the annotators and updating the guidelines 
For domain annotation, annotators with specific knowledge backgrounds are desirable. 
Consequently, two Masters students in medicine were employed and trained as annotators. The 
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training process follows an iterative method, each repetition can be summed up as follows:  
Phase 1: A set of discharge summaries and progress notes for 15 randomly selected 
patients were provided to both annotators for labeling. 
Phase 2: After completing the annotation, the IAA of the two annotated corpus was 
calculated to evaluate the degree to which the annotators were in agreement. For the IAA 
calculation, one annotated database is used as the gold standard, and the other is compared to 
the standard to compute the precision, recall, and F1-measure. Here, standard precision, recall, 
and F1-measure equations were adopted; their calculations are as follows: 
 
( 1, 2)
( 2)
Agreement A A
precision
Annotation A
 ，                       (1) 
 
( 1, 2)
( 1)
Agreement A A
recall
Annotation A
 ，                        (2) 
1
2
= .
precision recall
F
precision recall
 

                         (3) 
Here, we regarded the annotations of annotator 1A  as gold standard and evaluated the 
quality of annotator 2A ’s annotations. The  1,  2Agreement A A  refers to the same 
annotations made by the two annotators. More calculation details can be found in Hripcsak and 
Rothschild [41]. 
Phase 3: The two annotations were compared and any uncertainties were discussed by 
both the linguists and the annotators. A voting method was used to obtain a final agreement. 
Phase 4: The annotation guidelines were updated. In particular, errors found during 
phase 3 were added to the positive or negative examples and, when necessary, the guidelines 
were modified.  
This procedure was iteratively conducted until the IAA calculated in Phase 2 achieved 
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a continuously high value. In total, five repetitions were carried out; the resulting IAA values 
are listed in Table 2. 
 
Table 2 IAA values achieved during the iterative training process 
 Iteration 1 Iteration 2 Iteration 3 Iteration 4 Iteration 5 
Precision 0.810 0.977 0.967 0.986 0.988 
Recall 0.815 0.977 0.962 0.986 0.988 
F1-measure 0.812 0.977 0.964 0.986 0.988 
 
As Table 2 shows, the iterations obtained very high IAAs. All the F1-measures values 
were above 0.964 except for Iteration 1, in which the low score was probably caused by the 
initial unfamiliarity of annotators with the annotation guidelines and tools. Subsequent 
iterations obtained surprisingly high scores, indicating that the annotators and guidelines were 
truly ready to perform the corpus annotation. 
Corpus construction 
The annotators were asked to capture annotations from CEMRs for the 600 patients 
using the updated annotation guidelines. Moreover, to create a high quality annotated corpus, 
three measures were taken. One was that, the annotators could press a button on the annotation 
tool to indicate that they were unsure of the accuracy of a current annotation. Those 
uncertainties could be collected and discussed later. Another measure involved the use of 
overlapped documents (discharge summaries and progress notes of 25 patients), which were 
distributed to both annotators. These twice-annotated records were used to calculate the IAA 
and to monitor the quality of the entire annotation evaluation. The last measure was a random 
19 
 
sampling check on the annotations (at least one third were selected) by the linguists. When 
problems were found, discussions were held and the guidelines were updated. 
RESULTS 
In total, in the CVD risk factor annotated corpus comprising the discharge summaries 
and progress notes for all the 600 patients, there are 9,678 annotations associated with the 12 
CVD risk factors. Of these, the “mention” indicator type garners 63.5%, while the “drug” 
indicator type is rare (due to our restriction in the annotation guidelines that medication must 
be confirmed to be treated as a risk factor). Among the risk factors, hypertension is prominent 
in CEMR, with 3,729 annotations. Age and gender annotations occur at the same rate as Bp 
because they are basic patient attributes that are routinely recorded before diagnosis. The 
distributions of the four assertions (present, absent, possible, and not associated with patient) 
were 69.7, 19.2, 11.0, and 0.1 percent, respectively. The “present” assertion type occur most 
often because positive descriptions may have more significance when creating the medical 
records. 
Annotation quality and analysis 
Reasonably, the IAA values for the final corpus should be as high as the IAA values 
obtained during the training process due to the work performed before and during the formal 
annotation to guarantee sufficient quality. The final IAA calculations resulted in 0.971 for 
precision, 0.965 for recall and 0.968 for the F1-measure; these values demonstrate the high 
quality of the corpus.  
Table 3 shows the distribution of risk factors, indicators, temporal attributes and 
assertions. Each row in the table shows the distribution of a single indicator over the entire 
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corpus in different time and assertion partitions.  
--Table 3 about here-- 
For hypertension, “high Bp” is the most common indicator and “mention” is second. 
Approximately 2 “mention” and 3 “high Bp” indicators appear in each patient’s records. The 
“mention” annotations are mostly continuing and usually fixed over short durations, while 
“high Bp” annotations tend to occur during DHSs because Bp measurements are taken during 
physical examinations. Meanwhile, 78.7 percent of the “regulate Bp” annotations occur during 
DHSs because controlling Bp is a standard treatment for hypertensive individuals. 
Compared with “high Bp”, annotations identifying “high blood glucose” are far less 
common because of the complicated testing technique for blood glucose. In Table 3, the 
“mention” annotations comprise 86.7% of all the diabetes annotations for this risk factor, and 
64.1% of these “mention” annotations are “continuing, absent.” From earlier discoveries in the 
records, we knew that “否认高血压、糖尿病病史” (denying a history of hypertension and 
diabetes) occurs frequently. 
The spotlight indicator of dyslipidemia annotations is “regulate blood lipids”, because 
“调节血脂” (to regulate blood lipids) is a representative narrative in the assessment and plan 
section of dyslipidemia records. Moreover, for the same reason, the timing of this indicator is 
clustered around “during DHS, present”. 
When considering CKD, OSAS and FHCVD, the only indicator “mention” occurs 
infrequently. It occurs the most with CKD but still fewer than 26 times. Meanwhile, there is no 
“absent” assertion for any of these annotations. 
Atherosclerosis for “稳定冠脉粥样斑块” (stabilizing coronary atheromatous plaque) 
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has a relatively high number of mentions in our corpus and occurs repeatedly in the assessment 
and planning sections of CEMRs.  
The number of smoking annotations is relatively high (508 annotations among the 
records of 600 patients). “Mention” and “smoking amount” account for almost all the 
occurrences. The 380 “mention” and 119 “smoking amount” annotations include the 
“continuing” assertion because tobacco use is generally a habit, and quitting rarely occurs over 
a short period. 
There are numerous references to alcohol in the narratives of CEMRs, such as “否认吸
烟、饮酒史” (denying the history of smoking and drinking) and “间断少量饮酒史” (a history 
of intermittent small amounts of alcohol). However, these were not tagged as alcohol abuse 
because the patient’s intake is none or a slight. In contrast, serious usage has only 76 “mention” 
and 19 “drinking amount” annotations in our corpus and nearly all those are continuing. 
Age and gender are rich basic information in CEMRs. As with actual discoveries in the 
narratives of CEMRs, most “mention” annotations for age and gender occur in the 
hospitalization information section of discharge summaries and in the complaint, case 
characteristics and diagnosis basis sections of progress notes. Occasionally, “age group” occurs 
in the case characteristics and diagnosis basis sections.  
DISCUSSION 
We developed a corpus of CVD risk factor annotations including indicators, temporal 
attributes and assertions. Linguists and clinicians cooperated throughout the entire corpus 
construction process—from drafting annotation guidelines to discussing disagreements. The 
final IAA values achieved for this corpus reflects its high level.  
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In our corpus, a test value was annotated whether a test outcome was above or below a 
standard threshold. This was intentional and was designed to build a complete record of risk 
factor variation over the long term. For hypertension, we annotated all the Bp values regardless 
of whether they were above the standard 140/90 mmHg. Based on these annotations, when 
supervising an individual’s long-term health condition, the trained IE system can extract all the 
Bp conditions with no omissions and can then provide a visualization of the Bp variations over 
time. An appropriate warning or intervention treatment could then be applied at critical 
variation points. 
Annotations of therapeutic methods such as blood glucose regulation and hypoglycemic 
drug administration supports optional treatment recommendations. The trained IE system, after 
extracting the information from large numbers of CEMRs, can provide clinicians with referable 
treatments when it finds a similar condition in a current patient. Along a time dimension, these 
extractions can provide a clear assessment of treatment effects, for example, when a need to 
regulate glucose was recognized but glucose treatments were later stopped could show that the 
regulating treatment had a positive effect. This is significant because it allows clinicians to treat 
similar patients and decide which treatment would be better. 
The annotations of O2, hypertension, diabetes, dyslipidemia, CKD, and Atherosis can 
play a role in managing these chronic diseases. An IE system can extract an individual’s 
characteristics, such as examination values and medications. Then, a long term monitoring 
platform can monitor variations in these characteristics, provide feedback on treatments effects, 
and predict disease tendencies. Globally, nearly one billion people have high blood pressure; 
in 2008, diabetes was responsible for 1.3 billion deaths; high cholesterol was estimated to have 
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caused 2.6 million deaths; and at least 2.8 million people die each year as a result of being 
overweight or obese [5]. Consequently, a monitoring platform that aids in managing these 
chronic diseases can significantly reduce the suffering they cause to many patients and, thus, 
reduce CVD.  
CONCLUSION 
This paper describes the construction of an annotated corpus of CVD risk factors in 
CEMRs. To the best of our knowledge, this is the first Chinese corpus that concerns risk factors 
for CVD. We engaged both clinicians and annotators to draft guidelines and annotate the 
medical records. We proposed an annotation method that results in high quality annotations; 
the presented IAA values indicate the high quality of the resulting corpus. These document-
level risk factor annotations, along with the included temporal attributes and assertions, can be 
utilized in future studies of risk factor progression and their relationships with CVD over time. 
This corpus can play a significant role in developing a future IE system that can extract CVD 
risk factors from CEMRs to build a clear picture of individuals’ CVD risk factors and 
conditions, and it makes developing a monitoring platform to supervise the progression of risk 
factors and CVD possible. The related annotation resources are publicly available at 
https://github.com/WILAB-HIT/RiskFactor. 
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TABLES 
Table 3 Distribution of CVD risk factors, indicators, their occurrence times, and assertions 
Risk factors Indicators Before DHS During DHS After DHS Continuing    
  P A Pb N Total P A Pb N Total P A Pb N Total P A Pb N Total  Total 
O2 Mention 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18 0 0 0 18  18 
Hypertension Mention 0 1 0 0 1 0 0 1 0 1 0 0 0 0 0 526 401 471 0 1398  1400 
High Bp 304 0 0 0 304 1647 0 0 0 1647 0 0 0 0 0 2 1 1 0 4  1955 
Regulate Bp 56 0 0 0 56 244 0 0 0 244 10 0 0 0 10 0 0 0 0 0  310 
Blood pressure drug 43 1 0 0 44 17 0 0 0 17 0 0 0 0 0 0 3 0 0 3  64 
Diabetes Mention 2 0 0 0 2 1 0 0 0 1 0 0 0 0 0 172 558 138 3 871  874 
 High blood glucose 19 0 0 0 19 20 0 0 0 20 0 0 0 0 0 4 0 0 0 4  43 
 Regulate blood glucose 8 0 0 0 8 28 0 0 0 28 6 0 0 0 6 0 0 0 0 0  42 
 Hypoglycemic drug 31 0 0 0 31 8 0 0 0 8 7 0 0 0 7 2 0 0 0 2  48 
Dyslipidemia Mention 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 45 4 24 0 73  73 
 High blood lipids 0 0 0 0 0 4 0 0 0 4 0 0 0 0 0 2 0 0 0 2  6 
 Regulate blood lipids 2 0 0 0 2 249 0 0 0 249 5 0 0 0 5 0 0 0 0 0  256 
 Lip-lowering drug 2 0 0 0 2 34 0 0 0 34 1 0 0 0 1 0 0 0 0 0  37 
CKD Mention 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9 0 17 0 26  26 
Atherosis Mention 3 0 0 0 3 4 0 0 0 4 0 0 0 0 0 136 0 1 0 137  144 
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OSAS Mention 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1  1 
Smoking Mention 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 231 149 0 0 380  380 
 Smoking cessation 5 2 0 0 7 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1  8 
 Smoking amount 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 119 0 0 0 119  120 
A2 Mention 9 0 0 0 9 0 0 0 0 0 0 0 0 0 0 52 15 0 0 67  76 
Drinking amount 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19 0 0 0 19  19 
FHCVD Mention 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10 0 0 0 10  10 
Age Mention - - - - - - - - - - - - - - - - - - - -  1233 
 Age group - - - - - - - - - - - - - - - - - - - -  626 
Gender Mention - - - - - - - - - - - - - - - - - - - -  1909 
P: Present, A: Absent, Pb: Possible, N: Not associated with the patient. “-” denotes not considered. 
 
 
